The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells
Open accessAbstract
We have developed a bioartificial liver support system utilizing hollow-fiber bioreactor, plasmapheresis and microcarrier cell culture technologies. Liver cells were obtained through portal vein perfusion with ethylenediaminetetraacetate or ethylenediaminetetraacetate/collagenase. A mathematical model of mass transport in a hollow-fiber module, at various plasma flow velocities and system configurations, was developed. The bioartificial liver's ability to carry out specific differentiated metabolic liver functions was tested in vitro and in vivo. A reproducible large-animal model of acute ischemic liver failure was developed. Most major first-generation cyclosporine and 19-nor terstosterone metabolites were isolated after substrate addition to the bioartificial liver in vitro. After bioartificial liver treatment for 6 hr (with dog or pig liver cells), dogs with acute liver failure had significantly lower serum ammonia and lactate levels and significantly higher serum glucose levels than did control animals treated with a bioartificial liver system inoculated with microcarriers alone. In addition, bioartificial liver-treated animals had significantly higher mean systolic blood pressures than did controls. Liver cell viability at the end of the 6-hr in vivo experiment was greater than 90%. (Hepatology 1993;17:258-265.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chapter 4 Preparation of Isolated Rat Liver Cells
Seglen, P. O. (1976) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61797-5 · Cited by 5,310
Disorders of motility and muscle tone with special reference to the corpus striatum
Wilson, S. A. K. (1925) · The Lancet · Cited by 1,409
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
O'Grady, J. G., Gimson, A. E. S., O'Brien, C. J., Pucknell, A., Hughes, R. D., & Williams, R. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90011-x · Cited by 538
Replacement of Liver Function in Rats by Transplantation of Microcarrier-Attached Hepatocytes
Demetriou, A. A., Whiting, J. F., Feldman, D., Levenson, S. M., Chowdhury, N. R., Moscioni, A. D., Kram, M., & Chowdhury, J. R. (1986) · Science · doi:10.1126/science.2426782 · Cited by 294
Self-citationHormonal control of rat liver regeneration
Leffert, H. L., Koch, K. S., Moran, T., & Rubalcava, B. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90418-9 · Cited by 243
EARLIER CHARCOAL HAEMOPERFUSION IN FULMINANT HEPATIC FAILURE
Gimson, A. E. S., Mellon, P. J., Braude, S., Canalese, J., & Williams, R. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90711-5 · Cited by 202
Hybrid bioartificial liver in hepatic failure: preliminary clinical report.
Matsumura, K. N., Guevara, G., Huston, H. K., Hamilton, W. L., Rikimaru, M., Yamasaki, G., & Matsumura, M. S. (1987) · PubMed · Cited by 186
Maurer, G., Loosli, H. R., Schreier, E., & Keller, B. (1984) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07677-9 · Cited by 161
TREATMENT OF FULMINANT HEPATIC FAILURE BY POLYACRYLONITRILE-MEMBRANE HÆMODIALYSIS
Silk, D. B. A., Trewby, P., Chase, R. A., Mellon, P. J., Hanid, M. A., Davies, M. J., Langley, P. G., Wheeler, P. G., & Williams, R. L. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90001-0 · Cited by 151
CONTROLLED TRIAL OF EXCHANGE-TRANSFUSION THERAPY IN FULMINANT HEPATITIS
Redeker, A., & Yamahiro, H. S. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91220-8 · Cited by 147
Analytical chemistry at the Games of the XXIIIrd Olympiad in Los Angeles, 1984.
Catlin, D. H., Kammerer, R. C., Hatton, C. K., Sekera, M. H., & Merdink, J. L. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.2.319 · Cited by 123
Development of bioartificial liver: Bilirubin conjugation in gunn rats
Arnaout, W. S., Moscioni, A. D., Barbour, R. L., & Demetriou, A. A. (1990) · Journal of Surgical Research · doi:10.1016/0022-4804(90)90079-h · Cited by 85
Self-citation
Cited by
Long-term storage of tissues by cryopreservation: critical issues
Karlsson, J. O. M., & Toner, M. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85562-1 · Cited by 619
Fulminant hepatic failure: Summary of a workshop
Hoofnagle, J. H., Carithers, R. L., Shapiro, C., & Ascher, N. (1995) · Hepatology · doi:10.1002/hep.1840210137 · Cited by 533
A microfabricated array bioreactor for perfused 3D liver culture
Powers, M. J., Domansky, K., Kaazempur‐Mofrad, M. R., Kalezi, A., Capitano, A., Upadhyaya, A., Kurzawski, P., Wack, K. E., Stolz, D. B., Kamm, R., et al. (2002) · Biotechnology and Bioengineering · doi:10.1002/bit.10143 · Cited by 462
Watanabe, F. D., Mullon, C. J.-P., Hewitt, W. R., Arkadopoulos, N., Kahaku, E., Eguchi, S., Khalili, T., Arnaout, W., Shackleton, C. R., Rozga, J., et al. (1997) · Annals of Surgery · doi:10.1097/00000658-199705000-00005 · Cited by 453
Self-citationA Review of Three-Dimensional In Vitro Tissue Models for Drug Discovery and Transport Studies
Elliott, N. T., & Yuan, F. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22257 · Cited by 449
Metadata
- Authors
- Rozga, J., Williams, F., Ro, M.-S., Neuzil, D. F., Giorgio, T. D., Backfisch, G., Moscioni, A. D., Hakim, R., & Demetriou, A. A.
- Venue
- Hepatology
- Published
- 1993-02
- Volume
- 17
- Issue
- 2
- Pages
- 258-265
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2045285037
- Cited by
- 276
- References
- 12
- FWCI
- 19.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.